—Top 4% of Global Applicants Selected to Compete for $800K in Non-Dilutive Funding and Unmatched Industry Access—

—Up to 13 Companies to Participate in American Heart Association and American Society of Plastic Surgeons Specialty Accelerator Tracks—

MedTech Innovator (MTI), the world’s largest and most impactful accelerator for medical technology startups, today announced the 65 companies selected for its highly competitive 2025 Accelerator Cohort. These companies, representing the top four percent of nearly 1,500 global applicants, will participate in MTI’s flagship four-month program designed to de-risk innovation and accelerate the path to U.S. market success.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250605284592/en/

The 2025 cohort includes early and mid-stage medical device, diagnostic, and digital health companies that will receive unparalleled mentorship, strategic guidance, and access to MTI’s world-class ecosystem of industry-leading strategic manufacturers, investors, providers, payers, patients, and other industry stakeholders. Participants also join the highest-performing peer network in the sector. MTI alumni have collectively brought over 400 products to market and raised $10 billion in follow-on funding. Companies in this year’s cohort will compete for a share of $800,000 in non-dilutive funding, with winners selected by audience vote at major industry conferences.

“MedTech Innovator’s accelerator is a comprehensive platform for risk mitigation and value creation that helps the world’s most promising medtech startups become investable,” said Paul Grand, CEO and founder. “Over the next four months, our 2025 cohort will work closely with MTI’s extensive network of mentors and partners to advance these innovative technologies toward U.S. market access and public health benefit.”

Following a rigorous evaluation process, MTI and its corporate partners invited 213 companies (15 percent of applicants) to pitch at this year’s MedTech Innovator Road Tour events in Los Angeles, College Park, Md., and Dublin. The 65 selected cohort companies received feedback from 430 subject matter experts and represent 17 U.S. states and 13 countries.

The MedTech Innovator 2025 Cohort includes:

• Cardiovascular & Interventional
  • Adaptyx Biosciences - Menlo Park, Calif.
  • Armor Medical - Atlanta
  • ARTINESS - Milano, Italy
  • CathVision - København NV, Denmark
  • Conform Medical - San Francisco
  • CircuCare - San Diego
  • Emboa Medical - West Lafayette, Ind.
  • Kelvin Health - Sofia, Bulgaria
  • IntelVasc - San Francisco
  • LightHearted AI Health - London
  • MedLumics - Madrid
  • Narwhal Medical - Minneapolis
  • Octin Health - Minneapolis
  • Peerbridge Health - Brentwood, Tenn.
  • Powerful Medical - New York
  • STENTiT - Eindhoven, Netherlands
  • SummaCor - San Diego
  • Toro Neurovascular - Irvine, Calif.
  • VQ Biomedical - Apex, N.C.
• Diagnostic & Monitoring
  • Crely Healthcare - Oxnard, Calif.
  • EpiWatch - Baltimore
  • Genalyte - San Diego
  • Indigo Diabetes - Gent, Belgium
  • Lumia Health - Boston
  • Luminoah - Charlottesville, Va.
  • Microplate Dx - Glasgow, United Kingdom
  • MiWEndo Solutions - Barcelona, Spain
  • Rivanna Medical - Charlottesville, Va.
  • Sonorous Neurovascular - Lake Forest, Calif.
  • SynchNeuro - Philadelphia
  • Wavelet - New Haven, Conn.
• Neurology
  • Icometrix - Leuven, Belgium
  • Precisis - Heidelberg, Germany
  • Reach Neuro - Bristol, R.I.
  • Samphire Neuroscience - San Francisco
  • Sinaptica Therapeutics - Cambridge, Mass.
  • Veravas - Austin, Texas
• Regenerative Medicine & Wound Care
  • Altrazeal Life Sciences - Addison, Texas
  • BioMimir - Sherbrooke, Canada
  • BRIJ Medical - Marietta, Ga.
  • GelSana Therapeutics - Aurora, Colo.
  • inSoma Bio - Durham, N.C.
  • MedCu Technologies - Herzliya, Israel
  • ReGelTec - Baltimore
  • Regenyx Medical - Rehovot, Israel
  • Tempo Therapeutics - San Diego
• Surgical & Orthopedic
  • Aesclepius Corporation - San Diego
  • Axia Orthopedics - Portland, Ore.
  • Cohesys - Toronto
  • Connected Consumables - Dresden, Germany
  • CytexOrtho - Durham, N.C.
  • HAPPE Spine - Grand Rapids, Mich.
  • Magnendo - Newton, Mass.
  • Magsorbeo Biomedical - Detroit
  • RadioClash - Houston
  • SutureTech - Durham, N.C.
  • Winter Innovations - Knoxville, Tenn.
• FemTech & Urology
  • Lady Technologies - San Francisco
  • MOMM Diagnostics - Basel, Switzerland
  • Multi4 Medical - Gothenburg, Sweden
  • Multiphze - Glendale, Calif.
  • RenewRX - Denver
  • Starling Medical - Houston
  • Teal Health - San Francisco
  • The Flume Catheter Company - Farnham, United Kingdom

This year’s program launches at the invitation-only Innovator Summit on June 24-26 in Mountain View, Calif. This event connects the leadership teams from the latest cohorts with MTI’s partners, alumni, and other healthcare innovation stakeholders. On June 27, the companies will showcase to investors at MedTech World in San Jose, Calif.

The MTI accelerator will culminate with a series of showcases and competitions. All 65 companies will participate October 5-8 in San Diego at The MedTech Conference, powered by AdvaMed, where companies will present in showcase panels and gain access to industry and investor partnering opportunities. The MTI early-stage finals competition will be held at The MedTech Conference on October 6. The MTI mid-stage finals competition will be held November 19-21 at the MedTech Strategist Innovation Summit in San Diego.

As part of this year’s accelerator, five companies will participate in the MTI/ASPS Plastic Surgery Accelerator track held in partnership with the American Society for Plastic Surgeons (ASPS); and up to eight will participate in the Heart and Brain Health Accelerator in collaboration with the American Heart Association Ventures and Center for Health Technology and Innovation (CHTI). Participants in these specialty tracks will receive additional mentorship from their respective sponsors/collaborators and opportunities to participate in additional industry events.

MedTech Innovator’s founding sponsors are Johnson & Johnson MedTech and Research Corporation Technologies. Annual program sponsors include Asahi Intecc, Becton Dickinson and Company, Dexcom, Edwards Lifesciences, NIPRO Medical, Olympus Corporation of the Americas, W. L. Gore & Associates, Zimmer Biomet, Andrews Cooper, BioT Medical, Cambridge Consultants, Canon Quality Group, Medmarc, Minnetronix Medical, PDV MedTech, ProLucid Technologies, PRIA Healthcare, Proxima Clinical Research, RegNav, Siemens, Veeva Systems, Velentium, and Veranex. MTI’s Association collaborators are the American Heart Association Ventures, the American Heart Association’s Center for Health Technology and Innovation (CHTI), and the American Society for Plastic Surgeons (ASPS). The organization’s industry partners include AdvaMed, DeviceTalks, Health+Commerce, MedTech Strategist, and Wilson Sonsini.

About MedTech Innovator

MedTech Innovator is the world’s largest accelerator of medical device, digital health, and diagnostic companies. Its mission is to improve human health by accelerating the growth of companies transforming patient care. MTI has been a catalyst for groundbreaking healthcare solutions, sourcing nearly 14,000 applicants and fostering the growth of over 700 graduates. Alumni have collectively raised $10 billion in follow-on funding and introduced 400+ products to the market, improving the health of millions worldwide. For more information about MedTech Innovator, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI’s website, follow them on LinkedIn, and subscribe to its monthly newsletter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250605284592/en/